14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.23 $7.87 Thursday, 25th Apr 2024 ARDX stock ended at $6.31. This is 1.87% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.53% from a day low at $6.23 to a day high of $6.45.
90 days $6.23 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Mar 20, 2024 $7.92 $7.94 $7.55 $7.80 6 765 874
Mar 19, 2024 $7.78 $8.25 $7.72 $8.02 6 143 393
Mar 18, 2024 $8.11 $8.18 $7.73 $7.84 6 068 225
Mar 15, 2024 $8.02 $8.23 $7.97 $8.10 10 954 818
Mar 14, 2024 $8.54 $8.62 $7.96 $8.03 5 759 739
Mar 13, 2024 $8.44 $8.67 $8.37 $8.64 4 927 806
Mar 12, 2024 $8.51 $8.67 $8.34 $8.42 4 494 733
Mar 11, 2024 $8.66 $8.82 $8.39 $8.49 4 761 122
Mar 08, 2024 $9.06 $9.15 $8.63 $8.69 4 379 802
Mar 07, 2024 $9.60 $9.61 $8.94 $8.97 5 049 032
Mar 06, 2024 $9.78 $9.79 $9.28 $9.53 6 204 824
Mar 05, 2024 $8.92 $9.83 $8.69 $9.59 8 265 603
Mar 04, 2024 $9.46 $9.52 $8.96 $9.04 5 488 277
Mar 01, 2024 $9.39 $9.72 $9.31 $9.34 4 758 903
Feb 29, 2024 $9.67 $9.71 $9.21 $9.32 4 457 580
Feb 28, 2024 $9.53 $9.75 $9.42 $9.46 3 949 850
Feb 27, 2024 $9.35 $9.76 $9.27 $9.67 6 846 302
Feb 26, 2024 $8.62 $9.37 $8.58 $9.29 6 133 686
Feb 23, 2024 $8.16 $9.09 $8.16 $8.68 11 431 338
Feb 22, 2024 $8.72 $8.89 $8.49 $8.82 8 626 330
Feb 21, 2024 $8.48 $8.63 $8.36 $8.50 4 466 691
Feb 20, 2024 $9.00 $9.06 $8.41 $8.55 5 546 845
Feb 16, 2024 $9.12 $9.23 $8.97 $9.04 5 046 600
Feb 15, 2024 $9.37 $9.40 $9.08 $9.30 3 757 496
Feb 14, 2024 $9.04 $9.46 $8.97 $9.28 4 757 640
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT